Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study-Reference-Cited by-同舟云学术

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Published:2020-10-17 Issue:6 Volume:15 Page:743-750
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Al Baghdadi Tareq,Garrett-Mayer Elizabeth,Halabi Susan,Mangat Pam K.^ORCID,Rich Patricia,Ahn Eugene R.,Chai Seungjean,Rygiel Andrew L.,Osayameh Olufunlayo,Antonelli Kaitlyn R.,Islam Samiha,Bruinooge Suanna S.,Schilsky Richard L.

Funder

Pfizer

AstraZeneca

Bayer Corporation

Boehringer Ingelheim

Bristol-Myers Squibb

Eli Lilly and Company

Genentech

Merck

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11523-020-00752-8.pdf

Reference44 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA A Cancer J Clin. 2018;68(1):7–30. https://doi.org/10.3322/caac.21442.

2. National Cancer Institute. SEER Cancer Stat Facts: Colorectal Cancer. Bethesda, MD. https://seer.cancer.gov/statfacts/html/colorect.html. Accessed 21 Feb 2020.

3. Tomlinson JS, Jarnagin WR, Dematteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25(29):4575–80. https://doi.org/10.1200/jco.2007.11.0833.

4. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344(14):1031–7. https://doi.org/10.1056/nejm200104053441401.

5. Pacheco JM, Gao D, Smith D, Purcell T, Hancock M, Bunn P, et al. Natural history and factors associated with overall survival in stage IV ALK-rearranged non-small cell lung cancer. J Thorac Oncol. 2019;14(4):691–700. https://doi.org/10.1016/j.jtho.2018.12.014.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib in Patients With Soft Tissue Sarcoma With CDK4 Amplifications: Results From the Targeted Agent and Profiling Utilization Registry Study;JCO Precision Oncology;2024-07

2. Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study;JCO Precision Oncology;2024-06

3. Efficacy and safety of FLT3 inhibitors in monotherapy of hematological and solid malignancies: a systemic analysis of clinical trials;Frontiers in Pharmacology;2024-05-17

4. Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study;Journal of Clinical Oncology;2024-05-15

5. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics;Therapeutic Innovation & Regulatory Science;2024-04-23